✦ LIBER ✦

Parkinson's transplant therapy faces setback

✍ Scribed by Check, Erika

Book ID: 109805700
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 84 KB
Volume: 424
Category: Article
ISSN: 0028-0836
DOI: 10.1038/424987a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cell Transplantation and Gene Therapy in

Cell Transplantation and Gene Therapy in Parkinson's Disease

✍ Dustin R. Wakeman; Hemraj B. Dodiya; Jeffrey H. Kordower 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—transplantation

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

P a m p l o n a . SPAIN. Recent experimental data suggest that different s t ~i a t a l efferent pathways mediate the actions of D -l and D -2 receptor subtypes in r a t s . In order to know whether this organization is a l s o evident in primates. we studied the ability of SCH 23390

Stem Cell Transplantation: A Promising T

Stem Cell Transplantation: A Promising Therapy for Parkinson’s Disease

✍ Wang, Yi; Chen, Sheng; Yang, Dehua; Le, Wei-dong 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 199 KB

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Levodopa

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Clozapine

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Cabergoline ( C b ) is a U-2 ergot derivative with a long active half-life O 4 8 h ) . In a n open rising dose study we added C b to levodopa+inhibitor in 3 0 parkinsonian patients w i t h motor fluctuations. C h m e a n daily dose w a s 13.3(6-20). given once a day. for a mean period of 1 8 . 3 16-

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Miscellaneous

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

r i e d m a n , B r o w n U n i v e r s i t y , P r o v i d e n c e , R h o d e I s l a n d , C. C a l e y , I n s t i t u t e f o r m e n t a l H e a l t h , C r a n s t o n , R h o d e I s l a n d W e r e v i e w e d our e x p e r i e n c e w i t h f l u o x e t i n e in i d i o p a t h i c P a r